Javelin names a new chief executive
March 4, 2008 06:52 PM
E-mail|
|Comments
()|
Text size
–
+
The Cambridge drug developer Javelin Pharmaceuticals Inc. has appointed Martin J. Driscoll as chief executive.
He previously was CEO of Pear Tree Pharmaceuticals Inc., a private company focused on developing prescription products for women.
Javelin also said Daniel B. Carr will become vice chairman of the board. He will continue to serve as chief medical officer.
(AP)
Comment
Permalink
E-mail
